Microbiota and cancer: Elucidating the role of Candida albicans in cancer progression

doi:10.5306/wjco.v16.i6.106847

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 6

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (0)

All Articles published online

The chart showing PDF series, HTML series, Tables (1-1) series.

Item

Count

PDF

HTML

Tables (1-1)

Sum=0

Jun 24, 2025 (publication date) through Jun 20, 2025

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Clinical Oncology

ISSN

2218-4333

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Evidence Review

World J Clin Oncol. Jun 24, 2025; 16(6): 106847
Published online Jun 24, 2025. doi: 10.5306/wjco.v16.i6.106847

Microbiota and cancer: Elucidating the role of Candida albicans in cancer progression

Di Wang, Hao-Ling Zhang, Hao-Long Zhang, Zhi-Jing Song, Sandai Doblin, Ping Lu

Di Wang, Ping Lu, Department of Oncology, The First Affiliated Hospital of Xinxiang Medical University, Weihui 453000, Henan Province, China

Di Wang, Department of Biomedical Science, Universiti Sains Malaysia, Penang 13200, Malaysia

Hao-Ling Zhang, Sandai Doblin, Department of Biomedical Sciences, Advanced Medical and Dental Institute, Universiti Sains Malaysia, Penang 13200, Malaysia

Hao-Long Zhang, Advanced Medical and Dental Institute, Universiti Sains Malaysia, Penang 13200, Malaysia

Zhi-Jing Song, Clinical College of Chinese Medicine, Gansu University of Chinese Medicine, Lanzhou 730000, Gansu Province, China

Co-corresponding authors: Sandai Doblin and Ping Lu.

Author contributions: Wang D, Zhang HL and Zhang HL wrote the paper; Song ZJ, Doblin S, Lu P revised the paper.

Conflict-of-interest statement: The authors declare that they have no conflict of interest.

Open Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/

Corresponding author: Ping Lu, MD, Doctor, Department of Oncology, The First Affiliated Hospital of Xinxiang Medical University, No. 88 Jiankang Road, Weihui 453000, Henan Province, China. lupingdoctor@163.com

Received: March 9, 2025
Revised: April 9, 2025
Accepted: May 21, 2025
Published online: June 24, 2025
Processing time: 103 Days and 13.7 Hours

Core Tip

Core Tip: This review explores the role of Candida albicans (C. albicans), an opportunistic fungus, in cancer progression, particularly in digestive tract malignancies. It examines the interactions between C. albicans and the host, highlighting its relationship with the intestinal microbiota. The study also addresses the ongoing debate about whether C. albicans contributes to cancer development or is merely a complication of cancer. By identifying gaps in current research, this review seeks to open new directions for cancer screening, diagnosis, and treatment.